Abeona Therapeutics, Inc. (ABEO)
5.385
-0.10
(-1.73%)
USD |
NASDAQ |
Apr 21, 15:24
Abeona Therapeutics EPS Diluted (Quarterly) : -0.3717 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | -1.223 |
| Plus Therapeutics, Inc. | -1.03 |
| Atossa Therapeutics, Inc. | -1.270 |
| Cell Source, Inc. | -0.0153 |
| Kiora Pharmaceuticals, Inc. | -1.732 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.46M |
| Revenue (Quarterly) | 5.42M |
| Total Expenses (Quarterly) | 25.88M |
| Enterprise Value | 146.19M |
| Gross Profit Margin (Quarterly) | 31.73% |
| Profit Margin (Quarterly) | -377.5% |
| Earnings Yield | 18.52% |
| Normalized Earnings Yield | 16.66 |